Premium

coronavirus stock Ashburn 1

coronavirus stock Ashburn 1

An Oak Street Health clinic

Courtesy Oak Street Health


This story is available exclusively to Business Insider subscribers.
Become an Insider and start reading now.

  • The primary care startup Oak Street Health started trading on Thursday after pricing its shares at $21 apiece. Shares closed up 90% at $40 each.
  • The company will raise a little over $328 million after offering 15.6 million shares.
  • The founders of the company and its backers including General Atlantic hold stakes worth hundreds of millions after the initial public offering.
  • Visit Business Insider’s homepage for more stories.

The primary-care startup Oak Street Health just surged in its IPO, delivering a windfall to the company’s founders and backers.

The stock climbed 90% to $40 in its first day of trading, after Oak Street priced the offering at $21.

Oak Street raised roughly $328 million, based on the 15.6 million shares it planned to sell. The open pricing sets Oak Street’s valuation at $5 billion, and that had nearly doubled to $9.5 billion by the close on Thursday.

Founded in 2012, Oak Street has 260 primary care doctors in its 54 centers, managing the health of 85,000 patients. 

The IPO exposes a hot upstart that aims to transform healthcare to the scrutiny of public markets. It follows clinic operator One Medical, which went public in January, and has surged since its stock-market debut.

Coronavirus stock In its filing, Oak Street listed the top shareholders in the company and their stakes:

  • General Atlantic, a private equity firm, owns 34% of Oak Street or 76.4 million shares going into the IPO. At close, that stake was worth nearly $3.1 billion.
  • Newlight Partners, a private investment firm, owns 23% of Oak Street, or 50.4 million shares going into the IPO. That stake is now worth $2 billion.
  • Humana, the health insurer, owns 5.7% of Oak Street. Its 12.7 million shares are now worth $508 million.
  • Mike Pykosz, 38, is a cofounder and the CEO and chairman of Oak Street. He owns 9.4 million shares of Oak Street, or 4.2% going into the IPO, a stake worth $377 million. 
  • Geoff Price, 38, a cofounder and the chief operating officer, owns 7.8 million shares of Oak Street, or 3.5% going into the IPO. Price’s stake is worth $313 million.
  • Dr. Griffin Myers, 39, a cofounder and the chief medical officer, owns 6.5 million shares of Oak Street, a 2.9% stake going into the IPO. His shares are worth $260 million.

Coronavirus stock Investors are betting big on primary care

Oak Street’s IPO adds to an eventful year for privately held primary-care companies. In February, Medicare Advantage-focused Iora Health raised an additional $126 million from investors. In July, Walgreens made a $1 billion bet on primary care company VillageMD, with plans to open 500-700 doctors offices at Walgreens’ pharmacies over the next three years.  

The intense interest in primary care comes as the coronavirus pandemic creates massive challenges for every part of the healthcare industry. Healthcare workers are facing layoffs, furloughs, and reassignments, even as hospitals were overwhelmed by COVID-19 patients. Primary care practices that are paid based on the number of patients they see in a given day have seen heavy financial losses, while those that are working to get paid a large fixed sum each month to take care of all of a patient’s health needs haven’t seen the same hit

Chicago-based Oak Street is aiming to be in the latter group, striking contracts with health insurers to provide primary care to seniors, in particular those who are eligible for both Medicare and Medicaid. It works with Medicare Advantage health plans and those on traditional Medicare to get paid to manage the health of members, by driving them to and from appointments, and offering them social events and more time with their doctors.

Oak Street made $201.8 million in revenue in the first quarter of 2020, up from the $117.4 million it brought in between January and March 2019. For the full year 2019, Oak Street’s revenue was $556.6 million, up from $317.9 million in 2018.

The company’s net losses deepened as the company grew, the filing shows. From 2018 to 2019, losses widened from $79.5 million to $107.9 million. In the first quarter of 2020, Oak Street’s net loss was $15 million.

The Most Powerful Sale & Affiliate Platform Available!

There's no credit card required! No fees ever.

Create Your Free Account Now!

This article has been updated with Oak Street’s closing stock price on Thursday.

Loading Something is loading.

More:

BI Prime
Oak Street Health
Private Equity
IPO

Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options.